Review
Open access
Sep 2026
Hypoxia-inducible factor as a master switch in ocular neovascularization: overcoming anti-VEGF resistance and exploring therapeutic prospects
This review summarizes HIF-targeted strategies at the molecular, clinical, and emerging therapeutic levels, with a focus on the translational progress of lead candidates such as 32-134D and PX-478.
Teng Liu, Yi-Fei He, Yi-Fan Liao et al.
· Journal of Translational Med... · 0 citations